Disparity in hematological malignancies: From patients to health care professionals

Blood Rev. 2024 May:65:101169. doi: 10.1016/j.blre.2024.101169. Epub 2024 Jan 8.

Abstract

In the recent few decades, outcomes in patients diagnosed with hematological malignancies have been steadily improving. However, the improved prognosis does not distribute equally among patients from different backgrounds. Besides cancer biology, demographic and geographic disparities have been found to impact overall survival significantly. Specifically, patients from underrepresented minorities including Black and Hispanics, and those with uninsured status, having low socioeconomic status, or from rural areas have had worse outcomes historically, which is uniformly true across all major subtypes of hematological malignancies. Similar discrepancy is also seen in the health care professional field, where a gender gap and a disproportionally low representation of health care providers from underrepresented minorities have been long existing. Thus, a comprehensive strategy to mitigate disparity in the health care system is needed to achieve equity in health care.

Keywords: Disparity; Gender; Leukemia; Lymphoma; Myeloma; Race/ethnicity; Socioeconomic status.

Publication types

  • Review

MeSH terms

  • Health Personnel
  • Hematologic Neoplasms* / diagnosis
  • Hematologic Neoplasms* / epidemiology
  • Hematologic Neoplasms* / therapy
  • Hispanic or Latino*
  • Humans
  • Prognosis
  • United States
  • White